London, UK, 15 January 2009. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, today announced that it is funding industrial collaborative projects in two separate laboratories based in University College London (UCL). The first collaboration, with the groups of Professors Chris Mason and Nigel Titchener-Hooker, of the UCL Advanced Centre for Biochemical Engineering, will result [...]

London, UK, 1 October 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced it has received further funding from the Technology Strategy Board (TSB; formerly part of DTI) to apply its technologies towards developing a novel cell therapy designed to stimulate and sustain tissue regeneration. Plasticell is part of a consortium, additionally comprising [...]

London, UK, 1 August 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced the publication of a book chapter which presents the case for combinatorial methods in stem cell research. The chapter by Dr. Yen Choo, Plasticell’s founder, is entitled ‘Use of Combinatorial Screening to Discover Protocols That Effectively Direct the Differentiation of [...]

London, UK, 2 April 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has appointed Professor Tony Cass to its Scientific Advisory Board. Professor Cass is Professor of Chemical Biology, Deputy Director and Bio-nanotechnology Research Director in the Institute of Biomedical Engineering at Imperial College London. He is also a Founder and Executive Director of [...]

London, UK, 13 February 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with King’s College London (London, UK) to exploit and market two human embryonic stem cell (hESC) lines. hESC lines are specialized cells capable of forming all tissues of the body, and are thus a source of human [...]

London, UK, 14 January 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with Axordia Ltd (Sheffield, UK) to exploit and market a panel of six human embryonic stem cell (hESC) lines. hESC lines are specialized cells capable of forming all tissues of the body, and are thus a source [...]

London, UK, 13 November 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that Dr Yen Choo, the company’s Chief Executive, has been appointed to the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines. Dr Choo is the first member of the Committee recruited from [...]

London, UK, 9 October 2007. Plasticell Ltd is delighted to note that Sir Martin Evans, a founding member of the company’s Scientific Advisory Board, has been awarded this year’s Nobel Prize in Physiology or Medicine together with Mario Capecchi and Oliver Smithies for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem [...]